Correlation Between BioLife Sciences and Microbot Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLife Sciences and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLife Sciences and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLife Sciences and Microbot Medical, you can compare the effects of market volatilities on BioLife Sciences and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLife Sciences with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLife Sciences and Microbot Medical.

Diversification Opportunities for BioLife Sciences and Microbot Medical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioLife and Microbot is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioLife Sciences and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and BioLife Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLife Sciences are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of BioLife Sciences i.e., BioLife Sciences and Microbot Medical go up and down completely randomly.

Pair Corralation between BioLife Sciences and Microbot Medical

Given the investment horizon of 90 days BioLife Sciences is expected to generate 9.33 times more return on investment than Microbot Medical. However, BioLife Sciences is 9.33 times more volatile than Microbot Medical. It trades about 0.11 of its potential returns per unit of risk. Microbot Medical is currently generating about 0.03 per unit of risk. If you would invest  0.20  in BioLife Sciences on November 2, 2024 and sell it today you would lose (0.19) from holding BioLife Sciences or give up 95.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

BioLife Sciences  vs.  Microbot Medical

 Performance 
       Timeline  
BioLife Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Microbot Medical 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

BioLife Sciences and Microbot Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLife Sciences and Microbot Medical

The main advantage of trading using opposite BioLife Sciences and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLife Sciences position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.
The idea behind BioLife Sciences and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like